Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease
Molecular Therapy
· Elsevier
Аннотация
Publication date: 4 November 2026 Source: Molecular Therapy, Volume 34, Issue 11 Author(s): Oriana Mandolfo, Yuko Ishikawa Learmonth, Asma’u Usman, Maryann Lorino, Tereza Andreou, Rebecca Holley, Bei Qiu, Tristan Mckay, Brian W. Bigger
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Поиск и разработка лекарств»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all
“Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease.” Molecular Therapy.
@article{article90233,
title = {Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626006854?dgcid=rss_sd_all}
}